当前位置：药药网 / 药品 / 美国NDC复合药物数据库文件(本栏目更新到2026-3-31)
药品名称： 商品名称： 药品NDC： 报告期内： -格式:2020-5-3
NDC包装id： 市场分类： 活性成分： 持证企业：
 美国NDC复合药物数据库文件4843条(本栏目更新到2026-3-31)
药品名称(分析)
商品名
药品NDC
专利人(分析)
报告期内
活性成分
市场分类
规格(分析)
NDC包装id
141062 HYDROCORTISONE 2.5% / HYDROQUINONE 4% / TRETINOIN 0.025%
HUMAN COMPOUNDED DRUG
72934-6388
SKNV
2024-1
HYDROQUINONE; TRETINOIN; HYDROCORTISONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
4 g/100 mL; .025 g/100 mL; 2.5 g/100 mL
72934-6388-2
121020 HYDROCORTISONE 2.5% / KETOCONAZOLE 2%
HUMAN COMPOUNDED DRUG
72934-2369
SKNV
2024-1
KETOCONAZOLE; HYDROCORTISONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2 g/100 mL; 2.5 g/100 mL
72934-2369-2
031085 FINASTERIDE 0.1% / MINOXIDIL 7% / TRETINOIN 0.025%
HUMAN COMPOUNDED DRUG
72934-4353
SKNV
2024-1
FINASTERIDE; TRETINOIN; MINOXIDIL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.1 g/100 mL; .025 g/100 mL; 7 g/100 mL
72934-4353-8
Epinephrine
HUMAN COMPOUNDED DRUG
65302-507
The Ritedose Corporation
2024-2
EPINEPHRINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.1 mg/1 mL
65302-507-10
Atropine Sulfate
HUMAN COMPOUNDED DRUG
65302-508
The Ritedose Corporation
2024-2
ATROPINE SULFATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.4 mg/1 mL
65302-508-35
Labetalol Hydrochloride
HUMAN COMPOUNDED DRUG
65302-503
The Ritedose Corporation
2024-2
LABETALOL HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
5 mg/1 mL
65302-503-04
Succinylcholine Chloride
HUMAN COMPOUNDED DRUG
65302-504
The Ritedose Corporation
2024-2
SUCCINYLCHOLINE CHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg/1 mL
65302-504-05
Succinylcholine Chloride
HUMAN COMPOUNDED DRUG
65302-504
The Ritedose Corporation
2024-2
SUCCINYLCHOLINE CHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg/1 mL
65302-504-10
Labetalol Hydrochloride
HUMAN COMPOUNDED DRUG
82396-141
ANNOVEX PHARMA, INC.
2024-2
LABETALOL HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
5 mg/1 mL
82396-141-05
Rocuronium Bromide
HUMAN COMPOUNDED DRUG
82396-170
ANNOVEX PHARMA, INC.
2024-2
ROCURONIUM BROMIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg/1 mL
82396-170-10
Ephedrine Sulfate
HUMAN COMPOUNDED DRUG
82396-123
ANNOVEX PHARMA, INC.
2024-2
EPHEDRINE SULFATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
5 mg/1 mL
82396-123-10
Semaglutide 12.5mg and Cyanocobalamin 2.5mg
HUMAN COMPOUNDED DRUG
71170-690
Apollo Care, LLC
2024-2
SEMAGLUTIDE; CYANOCOBALAMIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2.5 mg/1 mL; .5 mg/1 mL
71170-690-01
Sarracenia Purpurea
HUMAN COMPOUNDED DRUG
69389-064
US Specialty Formulations LLC
2024-2
SARRACENIA PURPUREA
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
5 mg/1 mL
69389-064-22
Phenylephrine
HUMAN COMPOUNDED DRUG
73177-166
STAQ Pharma Inc
2024-2
PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
160 ug/1 mL
73177-166-25
Hydromorphone Hydrochloride
HUMAN COMPOUNDED DRUG
73177-117
STAQ Pharma Inc
2024-2
HYDROMORPHONE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL
73177-117-28
Hydromorphone Hydrochloride
HUMAN COMPOUNDED DRUG
73177-117
STAQ Pharma Inc
2024-2
HYDROMORPHONE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL
73177-117-27
Theophylline
HUMAN COMPOUNDED DRUG
73177-144
STAQ Pharma Inc
2024-2
THEOPHYLLINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1.55 mg/1 mL
73177-144-31
Theophylline
HUMAN COMPOUNDED DRUG
73177-145
STAQ Pharma Inc
2024-2
THEOPHYLLINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
3.1 mg/1 mL
73177-145-31
Phenylephrine
HUMAN COMPOUNDED DRUG
73177-112
STAQ Pharma Inc
2024-2
PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
40 ug/1 mL
73177-112-03
ESTRADIOL 6MG
HUMAN COMPOUNDED DRUG
73693-375
FARMAKEIO OUTSOURCING LLC
2024-2
ESTRADIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
6 mg
73693-375-01
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3